Preference-Weighted Health Status of PTSD Among Veterans: An Outcome for Cost-Effectiveness Analysis Using Clinical Data

被引:0
|
作者
Freed, Michael C. [1 ,2 ]
Yeager, Derik E. [3 ,4 ]
Liu, Xian [1 ,2 ]
Gore, Kristie L. [1 ,2 ]
Engel, Charles C. [1 ,2 ]
Magruder, Kathryn M. [3 ,4 ]
机构
[1] Walter Reed Army Med Ctr, Deployment Hlth Clin Ctr, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA
[3] Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
关键词
POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; UTILITY MEASURES; METAANALYSIS; SYMPTOMS; PHARMACOTHERAPY; AFGHANISTAN; PREVALENCE; VALIDATION; CHECKLIST;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Posttraumatic stress disorder (PTSD) is a highly prevalent, chronic, disabling but treatable condition. Preference-based measures (for example, health utilities) are recommended for and useful in cost-effectiveness analyses and for policy decisions because they reflect a population's valuation of the desirability of disease states. However, no such measures exist for PTSD. This study aimed to estimate preference-weighted health status associated with PTSD and common co-occurring mental disorders in a sample of veterans by transforming health-related quality-of-life data into preference-weighted health status scores (PWHS scores), develop a usable regression model to predict PWHS scores from other data sets, and compare preference-weighted health status of PTSD with that of another chronic disorder, chronic obstructive pulmonary disease (COPD). Methods: A secondary analysis was performed on data from a random sample of 808 veterans (79% male; 12% met criteria for PTSD) in four primary care clinics. Veterans responded to the PTSD Checklist (PCL), Clinician-Administered PTSD Scale, Mini-International Neuropsychiatric Interview, and Medical Outcomes Survey Short Form-36. Results: PWHS scores were .029 lower among veterans with PTSD compared with veterans without PTSD, all else being equal. However, scores depended on PTSD severity, when the analysis controlled for other model variables. Specifically, PWHS scores dropped by .004 with a 1-unit increase in PCL scores among veterans without PTSD. Among veterans with PTSD, the reduction was .002. PTSD was associated with lower preference-weighted health status than COPD. Conclusions: This is the first study to estimate preference-weighted health status of persons with PTSD. These PWHS scores can be helpful in cost-effectiveness studies of PTSD treatments. (Psychiatric Services 60: 1230-1238, 2009)
引用
收藏
页码:1230 / 1238
页数:9
相关论文
共 50 条
  • [21] The young osteoarthritic hip Clinical outcome of total hip arthroplasty and a cost-effectiveness analysis
    Busch, Vincent
    ACTA ORTHOPAEDICA, 2015, 86 : 3 - 21
  • [22] CURRENT STATUS OF REAL WORLD DATA USING FOR CONDUCTING COST-EFFECTIVENESS ASSESSMENTS IN JAPAN
    Hanada, K.
    Akazawa, M.
    VALUE IN HEALTH, 2018, 21 : S97 - S97
  • [23] Clinical FDG-PET for dementia in Japan: current status and cost-effectiveness analysis
    Senda, M
    Ouchi, Y
    Ishii, K
    Ishii, K
    Ikeda, S
    PET AND MOLECULAR IMAGING: STATE OF THE ART AND FUTURE PERSPECTIVES, 2004, 1264 : 33 - 39
  • [24] Using cost-effectiveness analysis to sharpen formulary decision-making: The example of tiotropium at the Veterans Affairs Health Care System
    Onukwugha, Ebere
    Mullins, C. Daniel
    DeLisle, Sylvain
    VALUE IN HEALTH, 2008, 11 (05) : 980 - 988
  • [25] Estimating Prevalence of PTSD Among Veterans With Minoritized Sexual Orientations Using Electronic Health Record Data
    Shipherd, Jillian C.
    Lynch, Kristine
    Gatsby, Elise
    Hinds, Zig
    DuVall, Scott L.
    Livingston, Nicholas A.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2021, 89 (10) : 856 - 868
  • [26] Using cost-effectiveness analysis to improve health care: opportunities and barriers.
    Anderson, Robert
    PUBLIC HEALTH, 2007, 121 (01) : 80 - 80
  • [27] ENHANCED COST-EFFECTIVENESS ANALYSIS USING EHR DATA FOR REAL WORLD VALUE
    Swaminathan, A.
    Xu, C.
    Zhang, S.
    Du, K.
    Siu, E.
    Kalesinskas, L.
    Lite, S.
    Song, Y.
    Snider, J.
    Ramsey, S.
    Bargo, D.
    Adamson, B.
    VALUE IN HEALTH, 2021, 24 : S26 - S26
  • [28] Retrospective Cost-Effectiveness Analysis of Treatments for Aphasia: An Approach Using Experimental Data
    Ellis, Charles
    Lindrooth, Richard C.
    Horner, Jennifer
    AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2014, 23 (02) : 186 - 195
  • [29] Cost-effectiveness of angiotensin receptor blockers in patients with hypertension: A comparative analysis using clinical trial and observational data
    Boersma, C.
    Voors, A. A.
    Van den Berg, P. B.
    Visser, S. T.
    De Jong-van den Berg, L. T.
    Postma, M. J.
    VALUE IN HEALTH, 2007, 10 (06) : A417 - A417
  • [30] USING SURROGATE FAILURE TIME DATA TO INCREASE COST-EFFECTIVENESS IN CLINICAL-TRIALS
    KOSOROK, MR
    FLEMING, TR
    BIOMETRIKA, 1993, 80 (04) : 823 - 833